[Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
作者信息
Sapary L, Horvath B, Alexy T, Marton Zs, Kesmarky G, Zsots M, Nagy F, Czopf I, Toth K
出版信息
Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(6):47-51.
PMID:16841484
Abstract
摘要
相似文献
1
[Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106(6):47-51.
2
Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases.
Phytomedicine. 2009 Mar;16(2-3):111-7. doi: 10.1016/j.phymed.2008.10.014. Epub 2009 Jan 8.
3
[About cavinton therapy of the patients with brain vascular diseases].
Voen Med Zh. 2007 Feb;328(2):43-5.
4
[Treatment of circulatory encephalopathy with Cavinton].
Klin Med (Mosk). 1997;75(11):51-3.
5
[A multicenter program on assessment of efficacy and safety of a new therapeutic scheme for patients with chronic cerebrovascular insufficiency].
Zh Nevrol Psikhiatr Im S S Korsakova. 2009;109(5 Suppl 2):44-8.
6
[Effect of cavinton on systemic and cerebral hemodynamics of patients with chronic cerebral circulatory insufficiency].
Zh Nevropatol Psikhiatr Im S S Korsakova. 1985;85(9):1338-42.
7
[Use of cavinton in neuropaediatrics].
Zh Nevrol Psikhiatr Im S S Korsakova. 2004;104(12):63-4.
8
[Trial of using Cavinton in cerebrovascular disorders].
Klin Med (Mosk). 1982 Oct;60(10):39-42.
9
[Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
Orv Hetil. 2003 May 18;144(20):973-8.
10
Vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders—a randomized controlled clinical study.
Biomed Res Int. 2014;2014:324307. doi: 10.1155/2014/324307. Epub 2014 Dec 7.
Zotero 插件